NORDTREAT Prospective Study on Inflammatory Bowel Disease

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

February 7, 2022

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2031

Conditions
Inflammatory Bowel Diseases (IBD)Crohn Disease (CD)Ulcerative Colitis (UC)
Trial Locations (17)

101

RECRUITING

Landspitali, Reykjavik

1714

RECRUITING

Østfold Kalnes, Grålum

3004

RECRUITING

Vestre Viken HF, Drammen

3103

RECRUITING

Sykehuset i Vestfold, Tønsberg

3710

RECRUITING

Sykehuset i Telemark, Skien

6200

NOT_YET_RECRUITING

University Hospital of Southern Denmark, Aabenraa

11691

RECRUITING

Ersta Sjukhus, Stockholm

17176

RECRUITING

Karolinska Universitetssjukhuset, Stockholm

57581

RECRUITING

Höglandssjukhuset Eksjö, Eksjö

58185

RECRUITING

Universitetssjukhuset i Linköping, Linköping

70185

RECRUITING

Universitetssjukhuset Örebro, Örebro

75185

RECRUITING

Akademiska Sjukhuset Uppsala, Uppsala

Unknown

NOT_YET_RECRUITING

SVS Esbjerg Hospital, Esbjerg

RECRUITING

Odense University Hospital, Odense

RECRUITING

OUH Svendborg Hospital, Svendborg

RECRUITING

SLB Vejle Hospital, Vejle

0424

RECRUITING

Oslo Universitetssykehus, Oslo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Nordic Bioscience A/S

INDUSTRY

collaborator

University Hospital Bispebjerg and Frederiksberg

OTHER

collaborator

Aalborg University

OTHER

collaborator

Colitis-Crohn Foreningen

OTHER

collaborator

Uppsala University

OTHER

collaborator

Örebro University, Sweden

OTHER

collaborator

Lovisenberg Diakonale Hospital

OTHER

collaborator

University of Oslo

OTHER

collaborator

University of Kiel

OTHER

collaborator

University Hospital of Southern Denmark

UNKNOWN

lead

University of Southern Denmark

OTHER

NCT05414578 - NORDTREAT Prospective Study on Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter